Asset profile
Gemcitabine
Small molecule
Approvedregulatory verdict
Evidence outlook
Approved: HR+/HER2- Metastatic Breast Cancer, Non-Small Cell Lung Cancer
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
track record: Partial signal
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
117 competitors in this universe: 1 direct rival (same mechanism and indication), 0 same-class, 116 same-indication.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Gemcitabine: this drug | Approved | Small molecule | ribonucleotide reductase / DNA polymerase (dCTP competition) | ||
| FF-10832 | Phase 2 | Small molecule | ribonucleotide reductase / DNA polymerase (dCTP competition) | ||
| Abemaciclib (Verzenio) | Approved | Small molecule | CDK4 and CDK6 | ||
| Afatinib (Gilotrif) | Approved | Small molecule | EGFR/HER1, HER2, HER4 | ||
| Alectinib (Alecensa) | Approved | Small molecule | ALK | ||
| Alpelisib (BYL719) | Approved | Small molecule | PI3K-alpha | ||
| Alymsys (bevacizumab-Maly) | Approved | Monoclonal antibody | VEGF-A | ||
| Amivantamab | Approved | Multispecific antibody | EGFR x c-MET | ||
| Anastrozole | Approved | Small molecule | Aromatase | ||
| Atezolizumab | Approved | Monoclonal antibody | PD-L1 | ||
| BAT1706 (Avzivi) | Approved | Monoclonal antibody | VEGF-A | ||
| BAY2927088 (Hyrnuo) | Approved | Small molecule | HER2 (ERBB2) exon 20 insertions and point mutations; also mutant-selective EGFR | ||
| Bevacizumab | Approved | Monoclonal antibody | VEGF-A, Vascular Endothelial Growth Factor Inhibitor | ||
| Bevacizumab-Awwb (MVASI) | Approved | Monoclonal antibody | VEGF-A | ||
| Binimetinib | Approved | Small molecule | MEK1/2 | ||
| Brigatinib | Approved | Small molecule | ALK |
…and 102 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Compare head-to-head
Upcoming events
(395 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (58)
October 2026 (5)
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-10-09 · NCT06447662 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma, Biliary Tract CancerActive not recruiting
Est. primary completion 2026-10-27 · NCT05775159 · CT.gov ↗
What to watch
Phase 2Gallbladder Cancer UnresectableRecruiting
Est. primary completion 2026-10-30 · NCT06591650 · CT.gov ↗
What to watch
Early phase / not applicableBiliary Tract Cancers (BTC)Recruiting
Est. primary completion 2026-10-30 · NCT06611345 · CT.gov ↗
What to watch
Phase 1Advanced Gastrointestinal, Biliary Tract, and Pancreatic CancersActive not recruiting
Est. primary completion 2026-10-31 · NCT06360354 · CT.gov ↗
What to watch
November 2026 (8)
Phase 3Nasopharyngeal CarcinomaActive not recruiting
Est. primary completion 2026-11 · NCT06118333 · CT.gov ↗
What to watch
Phase 2Pancreatic NeoplasmsRecruiting
Est. primary completion 2026-11 · NCT06767813 · CT.gov ↗
What to watch
Phase 2Non-muscle Invasive Bladder Cancer (NMIBC)Not yet recruiting
Est. primary completion 2026-11 · NCT06829823 · CT.gov ↗
What to watch
Phase 2Nausea and Vomiting Caused by ChemotherapyRecruiting
Est. primary completion 2026-11 · NCT07537660 · CT.gov ↗
What to watch
Phase 1Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 …Recruiting
Est. primary completion 2026-11-13 · NCT06454383 · CT.gov ↗
What to watch
Phase 2Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2026-11-17 · NCT06219941 · CT.gov ↗
What to watch
Phase 1/2Locally Advanced or Metastatic Pancreatic CancerRecruiting
Est. primary completion 2026-11-30 · NCT03579836 · CT.gov ↗
What to watch
Phase 3Locally Advanced Cervical Cancer, Gemcitabine, Chemo-radiotherapyRecruiting
Est. primary completion 2026-11-30 · NCT06156514 · CT.gov ↗
What to watch
December 2026 (45)
Phase 2Metastatic Pancreatic CancerActive not recruiting
Est. primary completion 2026-12 · NCT02340117 · CT.gov ↗
What to watch
Phase 2Unresectable Biliary Tract CancerActive not recruiting
Est. primary completion 2026-12 · NCT02632305 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12 · NCT02889666 · CT.gov ↗
What to watch
Phase 1/2Bladder Cancer, Metastatic Bladder Cancer, Urothelial CarcinomaActive not recruiting
Est. primary completion 2026-12 · NCT02989584 · CT.gov ↗
What to watch
Phase 2/3Relapsed/Refractory Diffuse Large B-cell LymphomaActive not recruiting
Est. primary completion 2026-12 · NCT04442022 · CT.gov ↗
What to watch
Phase 3Bladder Cancer, Bladder Urothelial CarcinomaRecruiting
Est. primary completion 2026-12 · NCT04574960 · CT.gov ↗
What to watch
Phase 3Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2026-12 · NCT04969731 · CT.gov ↗
What to watch
Phase 3Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer …Recruiting
Est. primary completion 2026-12 · NCT05281471 · CT.gov ↗
What to watch
Phase 2Bladder CancerActive not recruiting
Est. primary completion 2026-12 · NCT05531123 · CT.gov ↗
What to watch
Phase 2Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct CancerActive not recruiting
Est. primary completion 2026-12 · NCT06048133 · CT.gov ↗
What to watch
Phase 1/2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2026-12 · NCT06202261 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2026-12 · NCT06323239 · CT.gov ↗
What to watch
Phase 2Mibc, Muscle Invasive Bladder CancerNot yet recruiting
Est. primary completion 2026-12 · NCT06623162 · CT.gov ↗
What to watch
Phase 2Unresectable Biliary Tract CarcinomaRecruiting
Est. primary completion 2026-12 · NCT06749730 · CT.gov ↗
What to watch
Phase 2Biliary Tract Cancer, Advanced CancerNot yet recruiting
Est. primary completion 2026-12 · NCT07003815 · CT.gov ↗
What to watch
Phase 2/3EBV Infection, Stage II Nasopharyngeal Carcinoma AJCC v7, Stage III Nasopharyngeal Carcinoma AJCC v7 …Active not recruiting
Est. primary completion 2026-12-01 · NCT02135042 · CT.gov ↗
What to watch
Phase 1/2Pediatric Sarcoma, Refractory, Pediatric Sarcoma, RelapsedRecruiting
Est. primary completion 2026-12-01 · NCT05634369 · CT.gov ↗
What to watch
Phase 2Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic …Recruiting
Est. primary completion 2026-12-01 · NCT05655949 · CT.gov ↗
What to watch
Phase 3Nausea and Vomiting Caused by ChemotherapyRecruiting
Est. primary completion 2026-12-06 · NCT07716228 · CT.gov ↗
What to watch
Phase 2Bladder Flat Urothelial Carcinoma In Situ, Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8 …Active not recruiting
Est. primary completion 2026-12-09 · NCT04164082 · CT.gov ↗
What to watch
Phase 3Locally Advanced Pancreatic CancerRecruiting
Est. primary completion 2026-12-25 · NCT05653453 · CT.gov ↗
What to watch
Phase 2Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast CarcinomaRecruiting
Est. primary completion 2026-12-30 · NCT03606967 · CT.gov ↗
What to watch
Phase 2Biliary Tract CancerActive not recruiting
Est. primary completion 2026-12-30 · NCT06465563 · CT.gov ↗
What to watch
Phase 1/2Metastatic Pancreatic Ductal AdenocarcinomaActive not recruiting
Est. primary completion 2026-12-30 · NCT06646055 · CT.gov ↗
What to watch
Phase 2LymphomaActive not recruiting
Est. primary completion 2026-12-31 · NCT02436707 · CT.gov ↗
What to watch
Phase 3Hepatoblastoma, Carcinoma, HepatocellularActive not recruiting
Est. primary completion 2026-12-31 · NCT03017326 · CT.gov ↗
What to watch
Phase 1/2Locally Advanced Pancreatic CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT03652428 · CT.gov ↗
What to watch
Phase 2Advanced Pancreatic CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT04098081 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8Active not recruiting
Est. primary completion 2026-12-31 · NCT04115163 · CT.gov ↗
What to watch
Phase 1Lymphoma, B-CellActive not recruiting
Est. primary completion 2026-12-31 · NCT04161248 · CT.gov ↗
What to watch
Early phase / not applicablePancreatic Cancer, Proton TherapyRecruiting
Est. primary completion 2026-12-31 · NCT04894643 · CT.gov ↗
What to watch
Phase 2Bladder Cancer, Non-muscle InvasiveActive not recruiting
Est. primary completion 2026-12-31 · NCT05024734 · CT.gov ↗
What to watch
Phase 2Hodgkin LymphomaRecruiting
Est. primary completion 2026-12-31 · NCT05180097 · CT.gov ↗
What to watch
Phase 1/2Advanced Malignant TumorsActive not recruiting
Est. primary completion 2026-12-31 · NCT05229497 · CT.gov ↗
What to watch
Phase 2Biliary Tract CarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT05668884 · CT.gov ↗
What to watch
Phase 3Cervical Cancer, Cervix Cancer, Cervix NeoplasmRecruiting
Est. primary completion 2026-12-31 · NCT05764044 · CT.gov ↗
What to watch
Phase 3Advanced CholangiocarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT05823311 · CT.gov ↗
What to watch
Phase 2Pancreatic Cancer MetastaticRecruiting
Est. primary completion 2026-12-31 · NCT05969171 · CT.gov ↗
What to watch
Early phase / not applicableRecurrent Ovarian CarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT06292286 · CT.gov ↗
What to watch
Phase 2Relapsed/Refractory Large B-Cell LymphomaRecruiting
Est. primary completion 2026-12-31 · NCT06489808 · CT.gov ↗
What to watch
Phase 1/2Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8Recruiting
Est. primary completion 2026-12-31 · NCT06704191 · CT.gov ↗
What to watch
Phase 2Intrahepatic Cholangiocarcinoma (Icc)Recruiting
Est. primary completion 2026-12-31 · NCT06721286 · CT.gov ↗
What to watch
Phase 4Metastatic Biliary Tract Cancer, HER2 PositiveNot yet recruiting
Est. primary completion 2026-12-31 · NCT06818773 · CT.gov ↗
What to watch
Phase 2Primary Central Nervous System Lymphoma (PCNSL)Recruiting
Est. primary completion 2026-12-31 · NCT07014943 · CT.gov ↗
What to watch
Phase 2Bile Duct Carcinoma, Gall Bladder Cancer, Biliary Tract Cancer, CholangiocarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT07025174 · CT.gov ↗
What to watch
2027 (160)
January 2027 (15)
Phase 2Metastatic Pancreatic CancerActive not recruiting
Est. primary completion 2027-01 · NCT05827055 · CT.gov ↗
What to watch
Phase 2Pancreatic CancerNot yet recruiting
Est. primary completion 2027-01 · NCT06234072 · CT.gov ↗
What to watch
Phase 2Extrahepatic Cholangiocarcinoma, Unresectable Perihilar or Ductal CCARecruiting
Est. primary completion 2027-01 · NCT06440993 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorsRecruiting
Est. primary completion 2027-01 · NCT06741644 · CT.gov ↗
What to watch
Phase 2Advanced Pancreatic CancersRecruiting
Est. primary completion 2027-01 · NCT06770439 · CT.gov ↗
What to watch
Phase 2Advanced Urothelial Carcinoma, Probiotics, ImmunotherapyRecruiting
Est. primary completion 2027-01-01 · NCT06904573 · CT.gov ↗
What to watch
Phase 2Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8Not yet recruiting
Est. primary completion 2027-01-01 · NCT07332351 · CT.gov ↗
What to watch
Phase 1FIGO Stage IVA Ovarian Cancer, FIGO Stage IVB Ovarian Cancer, Platinum-Resistant Ovarian Carcinoma, Recurrent Fallopian Tube Carcinoma …Active not recruiting
Est. primary completion 2027-01-05 · NCT01970722 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2027-01-10 · NCT06345599 · CT.gov ↗
What to watch
Phase 1Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8Active not recruiting
Est. primary completion 2027-01-31 · NCT03816358 · CT.gov ↗
What to watch
Phase 3Urinary Bladder NeoplasmsActive not recruiting
Est. primary completion 2027-01-31 · NCT04241185 · CT.gov ↗
What to watch
Phase 3Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma …Recruiting
Est. primary completion 2027-01-31 · NCT04267848 · CT.gov ↗
What to watch
Phase 2Urinary Bladder CancerActive not recruiting
Est. primary completion 2027-01-31 · NCT05644041 · CT.gov ↗
What to watch
Phase 1/2Advanced Dedifferentiated Liposarcoma, Advanced Leiomyosarcoma, Advanced Soft Tissue Sarcoma, Metastatic Dedifferentiated Liposarcoma …Recruiting
Est. primary completion 2027-01-31 · NCT06498648 · CT.gov ↗
What to watch
Phase 2Relapsed or Refractory Aggressive B-Cell Non-Hodgkins LymphomaRecruiting
Est. primary completion 2027-01-31 · NCT06806033 · CT.gov ↗
What to watch
February 2027 (6)
Phase 2Infiltrating Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma, Stage III Bladder Urothelial CarcinomaActive not recruiting
Est. primary completion 2027-02-01 · NCT03609216 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Cancer, PDAC, Pancreatic Ductal AdenocarcinomaActive not recruiting
Est. primary completion 2027-02-01 · NCT05355298 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic CarcinomaRecruiting
Est. primary completion 2027-02-01 · NCT06770452 · CT.gov ↗
What to watch
Phase 1Pancreas CancerActive not recruiting
Est. primary completion 2027-02-02 · NCT05497778 · CT.gov ↗
What to watch
Phase 2Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast CarcinomaRecruiting
Est. primary completion 2027-02-12 · NCT06492759 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2027-02-20 · NCT06239727 · CT.gov ↗
What to watch
March 2027 (12)
Phase 2Urothelial CarcinomaActive not recruiting
Est. primary completion 2027-03 · NCT06632951 · CT.gov ↗
What to watch
Phase 3Diffuse Large B-cell LymphomaActive not recruiting
Est. primary completion 2027-03 · NCT06929624 · CT.gov ↗
What to watch
Phase 1Advanced Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2027-03 · NCT07348107 · CT.gov ↗
What to watch
Phase 2Olfactory NeuroblastomaRecruiting
Est. primary completion 2027-03-01 · NCT06255210 · CT.gov ↗
What to watch
Phase 2Urothelial Carcinoma Bladder, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma Urethra …Recruiting
Est. primary completion 2027-03-01 · NCT06983210 · CT.gov ↗
What to watch
Phase 2Intrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2027-03-30 · NCT05422690 · CT.gov ↗
What to watch
Phase 3Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Neoplasm, Fibrolamellar Carcinoma, Hepatoblastoma …Active not recruiting
Est. primary completion 2027-03-31 · NCT03533582 · CT.gov ↗
What to watch
Phase 2Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8Recruiting
Est. primary completion 2027-03-31 · NCT06064097 · CT.gov ↗
What to watch
Phase 2Resectable Intrahepatic Cholangiocarcinoma With High Risk of RecurrenceRecruiting
Est. primary completion 2027-03-31 · NCT06280508 · CT.gov ↗
What to watch
Phase 2Biliary Tract Cancers (BTC)Recruiting
Est. primary completion 2027-03-31 · NCT07398339 · CT.gov ↗
What to watch
Phase 1/2Advanced Pancreatic Cancer, Ductal Adenocarcinoma of PancreasActive not recruiting
Est. primary completion 2027-03-31 · NCT07777211 · CT.gov ↗
What to watch
April 2027 (7)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-04 · NCT05101551 · CT.gov ↗
What to watch
Phase 2Hodgkin LymphomaRecruiting
Est. primary completion 2027-04 · NCT06377566 · CT.gov ↗
What to watch
Early phase / not applicableLocally Advanced Pancreatic CancerRecruiting
Est. primary completion 2027-04-01 · NCT06494514 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Cancer ResectableNot yet recruiting
Est. primary completion 2027-04-01 · NCT06888674 · CT.gov ↗
What to watch
Phase 1/2Advanced Intrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2027-04-01 · NCT06956716 · CT.gov ↗
What to watch
Phase 2B-cell Non-Hodgkin's LymphomaActive not recruiting
Est. primary completion 2027-04-06 · NCT07081022 · CT.gov ↗
What to watch
Phase 3Bladder CancerNot yet recruiting
Est. primary completion 2027-04-15 · NCT06364904 · CT.gov ↗
What to watch
May 2027 (14)
Phase 2Biliary Tract Carcinoma, Gallbladder CarcinomaActive not recruiting
Est. primary completion 2027-05 · NCT02151084 · CT.gov ↗
What to watch
Phase 2Intrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2027-05 · NCT04891289 · CT.gov ↗
What to watch
Phase 2Neoplasms, Child, AdolescentRecruiting
Est. primary completion 2027-05 · NCT05999994 · CT.gov ↗
What to watch
Phase 2Intrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2027-05 · NCT06375915 · CT.gov ↗
What to watch
Phase 2Platinum-resistant Ovarian CancerRecruiting
Est. primary completion 2027-05 · NCT06710288 · CT.gov ↗
What to watch
Phase 2Combined Hepatocellular and CholangiocarcinomaNot yet recruiting
Est. primary completion 2027-05 · NCT06855225 · CT.gov ↗
What to watch
Phase 1/2Metastatic Biliary Tract CancerRecruiting
Est. primary completion 2027-05-01 · NCT06548412 · CT.gov ↗
What to watch
Phase 2Gallbladder Cancer UnresectableEnrolling by invitation
Est. primary completion 2027-05-01 · NCT07310069 · CT.gov ↗
What to watch
Phase 3Pancreatic CancerRecruiting
Est. primary completion 2027-05-14 · NCT06953999 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic CancerRecruiting
Est. primary completion 2027-05-15 · NCT06951997 · CT.gov ↗
What to watch
Phase 2Endometrial AdenocarcinomaRecruiting
Est. primary completion 2027-05-30 · NCT05548296 · CT.gov ↗
What to watch
Phase 2Lung CancerRecruiting
Est. primary completion 2027-05-30 · NCT06421298 · CT.gov ↗
What to watch
Phase 1/2Recurrent Osteosarcoma, Refractory OsteosarcomaActive not recruiting
Est. primary completion 2027-05-31 · NCT03598595 · CT.gov ↗
What to watch
Phase 3Intrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2027-05-31 · NCT05342194 · CT.gov ↗
What to watch
June 2027 (23)
Phase 3Locally Advanced Pancreatic CancerActive not recruiting
Est. primary completion 2027-06 · NCT03257033 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06 · NCT04999761 · CT.gov ↗
What to watch
Phase 2Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic AdenocarcinomaRecruiting
Est. primary completion 2027-06 · NCT05825066 · CT.gov ↗
What to watch
Phase 1/2Nasopharyngeal Cancinoma (NPC), Recurrent Nasopharynx Carcinoma, Metastatic Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2027-06 · NCT06802835 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2027-06 · NCT06851247 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06 · NCT06922591 · CT.gov ↗
What to watch
Phase 3Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8Active not recruiting
Est. primary completion 2027-06-01 · NCT03775265 · CT.gov ↗
What to watch
Phase 2Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid NeoplasmRecruiting
Est. primary completion 2027-06-01 · NCT03907475 · CT.gov ↗
What to watch
Phase 2Intrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2027-06-01 · NCT07570849 · CT.gov ↗
What to watch
Phase 1Borderline Resectable Pancreatic Ductal Adenocarcinoma, Locally Advanced Cholangiocarcinoma, Locally Advanced Pancreatic Adenocarcinoma …Recruiting
Est. primary completion 2027-06-01 · NCT07619313 · CT.gov ↗
What to watch
Phase 2Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2027-06-20 · NCT07163273 · CT.gov ↗
What to watch
Phase 4Pancreatic Cancer Non-resectableNot yet recruiting
Est. primary completion 2027-06-20 · NCT07302841 · CT.gov ↗
What to watch
Phase 1Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma …Active not recruiting
Est. primary completion 2027-06-30 · NCT03321643 · CT.gov ↗
What to watch
Phase 3Urothelial CarcinomaActive not recruiting
Est. primary completion 2027-06-30 · NCT03967977 · CT.gov ↗
What to watch
Phase 1/2Advanced Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, Pancreatic CancerActive not recruiting
Est. primary completion 2027-06-30 · NCT04396821 · CT.gov ↗
What to watch
Phase 1Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma, Advanced Endometrial Carcinoma …Active not recruiting
Est. primary completion 2027-06-30 · NCT04491942 · CT.gov ↗
What to watch
Phase 1/2Advanced CancerActive not recruiting
Est. primary completion 2027-06-30 · NCT04495296 · CT.gov ↗
What to watch
Phase 1Pancreatic Ductal Adenocarcinoma (PDAC)Recruiting
Est. primary completion 2027-06-30 · NCT06182072 · CT.gov ↗
What to watch
Phase 3Recurrent Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2027-06-30 · NCT06235203 · CT.gov ↗
What to watch
Phase 2Biliary Tract CancerNot yet recruiting
Est. primary completion 2027-06-30 · NCT06502080 · CT.gov ↗
What to watch
Phase 1/2Pancreatic CancerNot yet recruiting
Est. primary completion 2027-06-30 · NCT06513455 · CT.gov ↗
What to watch
Phase 2Gallbladder Cancer, CholangiocarcinomaEnrolling by invitation
Est. primary completion 2027-06-30 · NCT06963060 · CT.gov ↗
What to watch
Phase 2Biliary Tract NeoplasmsRecruiting
Est. primary completion 2027-06-30 · NCT07668453 · CT.gov ↗
What to watch
July 2027 (11)
Phase 2Mycosis Fungoides, Mycosis Fungoides/Sezary Syndrome, Sezary Syndrome, Sézary, Advanced Mycosis FungoidesActive not recruiting
Est. primary completion 2027-07 · NCT04960618 · CT.gov ↗
What to watch
Phase 2Pancreatic Cancer, Metastatic AdenocarcinomaRecruiting
Est. primary completion 2027-07 · NCT05776524 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic AdenocarcinomaRecruiting
Est. primary completion 2027-07 · NCT06576115 · CT.gov ↗
What to watch
Phase 1/2Triple Negative Breast CancerRecruiting
Est. primary completion 2027-07-01 · NCT06460298 · CT.gov ↗
What to watch
Phase 3Pancreatic Cancer MetastaticRecruiting
Est. primary completion 2027-07-01 · NCT06752811 · CT.gov ↗
What to watch
Phase 2Cholangiocarcinoma, Hilar Cholangiocarcinoma, Bile Duct CancerRecruiting
Est. primary completion 2027-07-01 · NCT07030140 · CT.gov ↗
What to watch
Phase 3HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-07-24 · NCT07088263 · CT.gov ↗
What to watch
Phase 1/2Anal Cancer Metastatic, Squamous Cell Carcinoma of the Anus Stage Unspecified, Pancreatic Cancer Metastatic …Active not recruiting
Est. primary completion 2027-07-30 · NCT07280377 · CT.gov ↗
What to watch
Phase 1Ovarian CancerRecruiting
Est. primary completion 2027-07-31 · NCT03854110 · CT.gov ↗
What to watch
Phase 2CholangiocarcinomaRecruiting
Est. primary completion 2027-07-31 · NCT05967182 · CT.gov ↗
What to watch
Phase 1/2NMIBC, Non-Muscle Invasive Bladder Urothelial Carcinoma, Bladder (Urothelial, Transitional Cell) Cancer, Urothelial Carcinoma BladderNot yet recruiting
Est. primary completion 2027-07-31 · NCT07064863 · CT.gov ↗
What to watch
August 2027 (13)
Phase 2Hodgkin Lymphoma, Relapsed or Refractory Hodgkin LymphomaRecruiting
Est. primary completion 2027-08 · NCT03618550 · CT.gov ↗
What to watch
Phase 2Metastatic Triple-Negative Breast CancerActive not recruiting
Est. primary completion 2027-08 · NCT06027268 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Basal Cell NeoplasmRecruiting
Est. primary completion 2027-08 · NCT06483555 · CT.gov ↗
What to watch
Phase 2Bladder CancerRecruiting
Est. primary completion 2027-08 · NCT06488222 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-08 · NCT06917079 · CT.gov ↗
What to watch
Phase 2Pancreatic CancerRecruiting
Est. primary completion 2027-08 · NCT06962267 · CT.gov ↗
What to watch
Phase 1/2Pancreatic CancerRecruiting
Est. primary completion 2027-08 · NCT07444541 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal Carcinoma, Nasopharyngeal CancerActive not recruiting
Est. primary completion 2027-08-01 · NCT05587374 · CT.gov ↗
What to watch
Phase 1Pancreatic Adenocarcinoma Non-resectableRecruiting
Est. primary completion 2027-08-01 · NCT07481383 · CT.gov ↗
What to watch
Phase 1/2Pancreas Cancer, Metastatic, Pancreas Cancer, Stage IV, Ductal Adenocarcinoma of the PancreasRecruiting
Est. primary completion 2027-08-01 · NCT07701486 · CT.gov ↗
What to watch
Phase 2Neoadjuvant Therapy, Urothelial Carcinoma Ureter, Upper Urinary Tract Urothelial CarcinomaActive not recruiting
Est. primary completion 2027-08-15 · NCT07492225 · CT.gov ↗
What to watch
Phase 2Pancreatic Adenocarcinoma, Resectable Pancreatic CancerRecruiting
Est. primary completion 2027-08-29 · NCT05624918 · CT.gov ↗
What to watch
Phase 2Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage I Pancreatic Cancer AJCC v8 …Recruiting
Est. primary completion 2027-08-31 · NCT06423326 · CT.gov ↗
What to watch
September 2027 (12)
Phase 1/2Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Follicular Lymphoma …Active not recruiting
Est. primary completion 2027-09 · NCT04542824 · CT.gov ↗
What to watch
Phase 2Urinary Bladder CancerNot yet recruiting
Est. primary completion 2027-09 · NCT07184021 · CT.gov ↗
What to watch
Phase 2Adenocarcinoma, Carcinoma, Pancreatic DuctalRecruiting
Est. primary completion 2027-09 · NCT07259317 · CT.gov ↗
What to watch
Phase 2Relapsed/Refractory Diffuse Large B Cell LymphomaRecruiting
Est. primary completion 2027-09 · NCT07451652 · CT.gov ↗
What to watch
Phase 2/3DLBCL, Diffuse Large B-Cell LymphomaRecruiting
Est. primary completion 2027-09-24 · NCT05139017 · CT.gov ↗
What to watch
Phase 1/2Soft Tissue Sarcoma, Sarcoma,Soft Tissue, Sarcoma, Soft Tissue Sarcoma AdultRecruiting
Est. primary completion 2027-09-29 · NCT04577014 · CT.gov ↗
What to watch
Phase 1Advanced MalignanciesActive not recruiting
Est. primary completion 2027-09-30 · NCT03233139 · CT.gov ↗
What to watch
Phase 2/3Renal Pelvis and Ureter Urothelial CarcinomaRecruiting
Est. primary completion 2027-09-30 · NCT04628767 · CT.gov ↗
What to watch
Phase 1/2Diffuse Large B-Cell Lymphoma, Follicular LymphomaActive not recruiting
Est. primary completion 2027-09-30 · NCT04663347 · CT.gov ↗
What to watch
Phase 1Metastatic Pancreatic CancerActive not recruiting
Est. primary completion 2027-09-30 · NCT06532331 · CT.gov ↗
What to watch
Phase 1/2Metastatic Pancreatic CancerNot yet recruiting
Est. primary completion 2027-09-30 · NCT06662669 · CT.gov ↗
What to watch
October 2027 (7)
Phase 2Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Carcinoma in Situ of Bladder, Non-Muscle-Invasive Bladder CancerNot yet recruiting
Est. primary completion 2027-10 · NCT07189793 · CT.gov ↗
What to watch
Phase 1/2Locally Advanced or Metastatic Pancreatic Cancer WithRecruiting
Est. primary completion 2027-10 · NCT07296341 · CT.gov ↗
What to watch
Phase 2Locally Advanced Pancreatic Cancer With KRAS G12D MutationRecruiting
Est. primary completion 2027-10 · NCT07438106 · CT.gov ↗
What to watch
Phase 2Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB, Pancreatic Cancer Stage IIINot yet recruiting
Est. primary completion 2027-10-01 · NCT05562297 · CT.gov ↗
What to watch
Phase 1/2Diffuse Large B Cell Lymphoma (DLBCL)Recruiting
Est. primary completion 2027-10-26 · NCT07124936 · CT.gov ↗
What to watch
Phase 2Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 …Active not recruiting
Est. primary completion 2027-10-30 · NCT04940286 · CT.gov ↗
What to watch
Phase 1/2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-10-31 · NCT06026657 · CT.gov ↗
What to watch
November 2027 (8)
Phase 1/2Non-Muscle Invasive Bladder Cancer (NMIBC)Active not recruiting
Est. primary completion 2027-11 · NCT04179162 · CT.gov ↗
What to watch
Phase 1/2Non-muscle Invasive Bladder CancerRecruiting
Est. primary completion 2027-11 · NCT05126472 · CT.gov ↗
What to watch
Phase 2Non Muscle Invasive Bladder CancerRecruiting
Est. primary completion 2027-11 · NCT06663137 · CT.gov ↗
What to watch
Phase 2Bladder (Urothelial, Transitional Cell) CancerRecruiting
Est. primary completion 2027-11 · NCT07019220 · CT.gov ↗
What to watch
Phase 3DLBCL - Diffuse Large B Cell LymphomaRecruiting
Est. primary completion 2027-11 · NCT07570823 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid Tumors Cancer, Pancreatic Ductal Adenocarcinoma, RAS MutationNot yet recruiting
Est. primary completion 2027-11 · NCT07678593 · CT.gov ↗
What to watch
Phase 2Diffuse Large B-Cell LymphomaRecruiting
Est. primary completion 2027-11-15 · NCT07001540 · CT.gov ↗
What to watch
Phase 1Malignant Neoplasm of Bone and Articular Cartilage, Malignant Neoplasms of Female Genital Organs …Recruiting
Est. primary completion 2027-11-30 · NCT03093909 · CT.gov ↗
What to watch
December 2027 (32)
Phase 2Phase II, Open-label, Parallel 2-arm, Multi-centerActive not recruiting
Est. primary completion 2027-12 · NCT05026905 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal Carcinoma, Recurrent or MetastaticActive not recruiting
Est. primary completion 2027-12 · NCT05294172 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-12 · NCT05431270 · CT.gov ↗
What to watch
Phase 1/2Gastric or Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer (BTC), Colorectal CancerRecruiting
Est. primary completion 2027-12 · NCT05482893 · CT.gov ↗
What to watch
Phase 4Nasopharyngeal Cancer RecurrentRecruiting
Est. primary completion 2027-12 · NCT06457503 · CT.gov ↗
What to watch
Phase 1Biliary Tract Cancer, CholangiocarcinomaRecruiting
Est. primary completion 2027-12 · NCT06546969 · CT.gov ↗
What to watch
Phase 1Pancreatic Ductal Adenocarcinoma (PDAC)Recruiting
Est. primary completion 2027-12 · NCT06639724 · CT.gov ↗
What to watch
Phase 1/2Advanced Pancreatic CancerRecruiting
Est. primary completion 2027-12 · NCT06821503 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-12 · NCT07007559 · CT.gov ↗
What to watch
Phase 2Biliary Tract CarcinomaRecruiting
Est. primary completion 2027-12 · NCT07099547 · CT.gov ↗
What to watch
Phase 2Pancreatic Ductal Adenocarcinoma (PDAC)Recruiting
Est. primary completion 2027-12 · NCT07255404 · CT.gov ↗
What to watch
Phase 2Muscle Invasive Bladder Cancer (MIBC)Recruiting
Est. primary completion 2027-12 · NCT07296705 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Cancer Non-resectableRecruiting
Est. primary completion 2027-12 · NCT07575191 · CT.gov ↗
What to watch
Phase 2Advanced Solid TumourRecruiting
Est. primary completion 2027-12-26 · NCT07111546 · CT.gov ↗
What to watch
Phase 2Pancreatic Cancer, Neoadjuvant TherapyNot yet recruiting
Est. primary completion 2027-12-30 · NCT06177522 · CT.gov ↗
What to watch
Phase 3Pancreatic CancerNot yet recruiting
Est. primary completion 2027-12-30 · NCT07272109 · CT.gov ↗
What to watch
Phase 2Pancreatic CancerRecruiting
Est. primary completion 2027-12-31 · NCT04683315 · CT.gov ↗
What to watch
Phase 2Pancreatic Neoplasm, Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic AdenocarcinomaRecruiting
Est. primary completion 2027-12-31 · NCT05083247 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-12-31 · NCT05601440 · CT.gov ↗
What to watch
Phase 1Metastatic Pancreatic AdenocarcinomaRecruiting
Est. primary completion 2027-12-31 · NCT06229496 · CT.gov ↗
What to watch
Phase 2Bladder CancerRecruiting
Est. primary completion 2027-12-31 · NCT06388720 · CT.gov ↗
What to watch
Phase 2Intrahepatic Cholangiocarcinoma, Chemotherapy Effect, ImmunotherapyNot yet recruiting
Est. primary completion 2027-12-31 · NCT06567600 · CT.gov ↗
What to watch
Phase 2Cholangiocarcinoma ResectableNot yet recruiting
Est. primary completion 2027-12-31 · NCT06569225 · CT.gov ↗
What to watch
Phase 2Rare TumourNot yet recruiting
Est. primary completion 2027-12-31 · NCT06692491 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal Cancer Recurrent, Nasopharyngeal Cancinoma (NPC)Not yet recruiting
Est. primary completion 2027-12-31 · NCT07129772 · CT.gov ↗
What to watch
Early phase / not applicableExtrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2027-12-31 · NCT07235007 · CT.gov ↗
What to watch
Phase 2Pancreatic Cystic NeoplasmRecruiting
Est. primary completion 2027-12-31 · NCT07529483 · CT.gov ↗
What to watch
Phase 2Extranodal NK/T-cell LymphomaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07554482 · CT.gov ↗
What to watch
Phase 2/3CholangiocarcinomaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07598318 · CT.gov ↗
What to watch
Phase 1/2Borderline Resectable Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07705919 · CT.gov ↗
What to watch
Phase 2Locally Advanced Ampulla of Vater Carcinoma, Locally Advanced Biliary Tract Carcinoma, Locally Advanced Extrahepatic Cholangiocarcinoma …Recruiting
Est. primary completion 2027-12-31 · NCT07780838 · CT.gov ↗
What to watch
2028 (100)
January 2028 (10)
Phase 1/2Advanced Cancer, Metastatic Cancer, Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer, Endometrial Cancer …Recruiting
Est. primary completion 2028-01 · NCT04657068 · CT.gov ↗
What to watch
Phase 2/3NPC, HNSCC, Recurrence, MetastasisNot yet recruiting
Est. primary completion 2028-01-01 · NCT06719479 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal Cancinoma (NPC), Nasopharyngeal CancerNot yet recruiting
Est. primary completion 2028-01-01 · NCT07385079 · CT.gov ↗
What to watch
Phase 2Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Active not recruiting
Est. primary completion 2028-01-01 · NCT07480850 · CT.gov ↗
What to watch
Phase 2Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma …Recruiting
Est. primary completion 2028-01-04 · NCT05733000 · CT.gov ↗
What to watch
Phase 2/3HER2-positive Breast Cancer, Metastatic Breast CancerNot yet recruiting
Est. primary completion 2028-01-16 · NCT07366840 · CT.gov ↗
What to watch
Early phase / not applicableUTUCRecruiting
Est. primary completion 2028-01-30 · NCT06167057 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal Cancinoma (NPC), Nasopharangeal CancerRecruiting
Est. primary completion 2028-01-30 · NCT07325539 · CT.gov ↗
What to watch
Phase 1/2Advanced Biliary Tract CarcinomaRecruiting
Est. primary completion 2028-01-30 · NCT07392541 · CT.gov ↗
What to watch
Phase 1Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-01-31 · NCT07024615 · CT.gov ↗
What to watch
February 2028 (1)
Phase 1Unresectable or Metastatic Advanced Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-02 · NCT06393400 · CT.gov ↗
What to watch
March 2028 (7)
Phase 2Hodgkin LymphomaActive not recruiting
Est. primary completion 2028-03 · NCT05502250 · CT.gov ↗
What to watch
Phase 3Diffuse Large B-Cell LymphomaActive not recruiting
Est. primary completion 2028-03 · NCT06508658 · CT.gov ↗
What to watch
Phase 2Intrahepatic Cholangiocarcinoma (Icc), Neoadjuvant TherapyRecruiting
Est. primary completion 2028-03-01 · NCT07847710 · CT.gov ↗
What to watch
Phase 2Biliary Tract CancerNot yet recruiting
Est. primary completion 2028-03-30 · NCT07599995 · CT.gov ↗
What to watch
Phase 3Diffuse Large B-cell LymphomaActive not recruiting
Est. primary completion 2028-03-31 · NCT04408638 · CT.gov ↗
What to watch
Early phase / not applicableBiliary Tract Cancer (BTC)Recruiting
Est. primary completion 2028-03-31 · NCT07466238 · CT.gov ↗
What to watch
Phase 2CLDN18.2 Positive, Gastric/Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-03-31 · NCT07483554 · CT.gov ↗
What to watch
April 2028 (5)
Phase 2Relapsed /Refractory DLBCLNot yet recruiting
Est. primary completion 2028-04 · NCT07542678 · CT.gov ↗
What to watch
Phase 2Urinary Bladder Cancer, Upper Tract Urothelial Cancer, Urothelial CancerRecruiting
Est. primary completion 2028-04-01 · NCT06822010 · CT.gov ↗
What to watch
Phase 3Metastatic HER2-positive Breast CancerRecruiting
Est. primary completion 2028-04-28 · NCT06435429 · CT.gov ↗
What to watch
Phase 2Peripheral T Cell Lymphoma, Relapse/RecurrenceActive not recruiting
Est. primary completion 2028-04-30 · NCT04984837 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal Cancinoma (NPC), Nasopharyngeal CancerNot yet recruiting
Est. primary completion 2028-04-30 · NCT07373990 · CT.gov ↗
What to watch
May 2028 (8)
Phase 2Metastatic Pancreatic Adenocarcinoma, Locally Advanced Pancreatic AdenocarcinomaRecruiting
Est. primary completion 2028-05 · NCT07076212 · CT.gov ↗
What to watch
Phase 1Osteosarcoma Recurrent, Osteosarcoma in Children, Relapsed Osteosarcoma, Refractory OsteosarcomaRecruiting
Est. primary completion 2028-05 · NCT07144254 · CT.gov ↗
What to watch
Phase 3Metastatic Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-05 · NCT07165951 · CT.gov ↗
What to watch
Phase 2/3Non Muscle Invasive Bladder CancerNot yet recruiting
Est. primary completion 2028-05 · NCT07198451 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-05 · NCT07418931 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Ductal Adenocarcinoma (PDAC), Second Line TreatmentNot yet recruiting
Est. primary completion 2028-05-07 · NCT07685470 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal Carcinoma (NPC), CTIT-Chemotherapy Induced ThrombocytopeniaNot yet recruiting
Est. primary completion 2028-05-30 · NCT07252375 · CT.gov ↗
What to watch
Phase 2/3Metastatic Pancreatic CancerRecruiting
Est. primary completion 2028-05-31 · NCT06361888 · CT.gov ↗
What to watch
June 2028 (16)
Phase 2Pancreatic Cancer, Adenocarcinoma of the Pancreas, AdenocarcinomaActive not recruiting
Est. primary completion 2028-06 · NCT04543071 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-06 · NCT05786924 · CT.gov ↗
What to watch
Phase 2Billiary Track CancerRecruiting
Est. primary completion 2028-06 · NCT06001658 · CT.gov ↗
What to watch
Phase 3Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC) …Recruiting
Est. primary completion 2028-06 · NCT07491445 · CT.gov ↗
What to watch
Early phase / not applicableCholangiocarcinomaNot yet recruiting
Est. primary completion 2028-06-01 · NCT06434493 · CT.gov ↗
What to watch
Phase 2Biliary Tract Cancer (BTC)Recruiting
Est. primary completion 2028-06-01 · NCT07733115 · CT.gov ↗
What to watch
Phase 3Recurrent Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8Recruiting
Est. primary completion 2028-06-05 · NCT07000084 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Ductal Adenocarcinoma (PDAC)Recruiting
Est. primary completion 2028-06-22 · NCT07235202 · CT.gov ↗
What to watch
Phase 2Pancreatic CancerActive not recruiting
Est. primary completion 2028-06-29 · NCT04241276 · CT.gov ↗
What to watch
Phase 1Solid Tumor, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal CancerRecruiting
Est. primary completion 2028-06-30 · NCT04516447 · CT.gov ↗
What to watch
Phase 3Recurrent Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2028-06-30 · NCT06228079 · CT.gov ↗
What to watch
Phase 3Non-muscle Invasive Bladder Cancer With Carcinoma in SituRecruiting
Est. primary completion 2028-06-30 · NCT06545955 · CT.gov ↗
What to watch
Phase 1/2Combination Therapy, Aggressive B-Cell Non-Hodgkin Lymphoma, EMB07, phaseI/IIRecruiting
Est. primary completion 2028-06-30 · NCT07432022 · CT.gov ↗
What to watch
Phase 3Metastatic Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2028-06-30 · NCT07445295 · CT.gov ↗
What to watch
Phase 2Liver CancerNot yet recruiting
Est. primary completion 2028-06-30 · NCT07685535 · CT.gov ↗
What to watch
Phase 2Gallbladder CancerNot yet recruiting
Est. primary completion 2028-06-30 · NCT07767994 · CT.gov ↗
What to watch
July 2028 (10)
Phase 2Pancreatic Ductal Adenocarcinoma (mPDAC)Recruiting
Est. primary completion 2028-07 · NCT06790602 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-07 · NCT07158489 · CT.gov ↗
What to watch
Phase 2/3Stage II Gallbladder Cancer AJCC v8, Stage IIA Gallbladder Cancer AJCC v8, Stage IIB Gallbladder Cancer AJCC v8 …Active not recruiting
Est. primary completion 2028-07-01 · NCT04559139 · CT.gov ↗
What to watch
Phase 1Muscle Invasive Bladder Urothelial CarcinomaEnrolling by invitation
Est. primary completion 2028-07-01 · NCT06204614 · CT.gov ↗
What to watch
Phase 2Cholangiocarcinoma, Biliary Tract Cancer (BTC)Not yet recruiting
Est. primary completion 2028-07-01 · NCT06903273 · CT.gov ↗
What to watch
Phase 2Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified …Recruiting
Est. primary completion 2028-07-01 · NCT06905509 · CT.gov ↗
What to watch
Phase 2Pancreas AdenocarcinomaRecruiting
Est. primary completion 2028-07-01 · NCT07043270 · CT.gov ↗
What to watch
Phase 4Biliary Tract Cancer (BTC)Recruiting
Est. primary completion 2028-07-01 · NCT07619235 · CT.gov ↗
What to watch
Phase 2CholangiocarcinomaRecruiting
Est. primary completion 2028-07-01 · NCT07673341 · CT.gov ↗
What to watch
August 2028 (5)
Phase 2Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast CancersActive not recruiting
Est. primary completion 2028-08 · NCT06449222 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-08-01 · NCT05800587 · CT.gov ↗
What to watch
Phase 2Solid TumorsRecruiting
Est. primary completion 2028-08-15 · NCT07492680 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell CarcinomaRecruiting
Est. primary completion 2028-08-23 · NCT06597565 · CT.gov ↗
What to watch
September 2028 (11)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-09 · NCT07020065 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Cancer, Metastatic, PDAC - Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-09 · NCT07049055 · CT.gov ↗
What to watch
Phase 3Pancreatic Cancer, AdultRecruiting
Est. primary completion 2028-09 · NCT07436741 · CT.gov ↗
What to watch
Phase 2Pancreatobiliary Cancers, Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-09 · NCT07769502 · CT.gov ↗
What to watch
Phase 1Non-Hodgkin Lymphoma, Cytokine Release SyndromeRecruiting
Est. primary completion 2028-09-01 · NCT06447376 · CT.gov ↗
What to watch
Phase 2LeiomyosarcomaRecruiting
Est. primary completion 2028-09-30 · NCT04535271 · CT.gov ↗
What to watch
Phase 1/2Colorectal Cancer, CRC, Pancreatic Ductal Adenocarcinoma, PDAC, Gastrointestinal Cancer, Metastatic Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-09-30 · NCT06445062 · CT.gov ↗
What to watch
Phase 2Nasopharynx CancerNot yet recruiting
Est. primary completion 2028-09-30 · NCT06611826 · CT.gov ↗
What to watch
Phase 1/2Metastatic Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-09-30 · NCT06904378 · CT.gov ↗
What to watch
Phase 2ORR,OS,PFSNot yet recruiting
Est. primary completion 2028-09-30 · NCT07328802 · CT.gov ↗
What to watch
October 2028 (5)
Phase 2Lymphoma, B-cell Lymphomas, Relapsed/Refractory Large B-cell Lymphoma, Large B-cell LymphomaNot yet recruiting
Est. primary completion 2028-10-01 · NCT07711483 · CT.gov ↗
What to watch
Phase 1Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma, Metastatic Malignant Neoplasm in the Peritoneum …Recruiting
Est. primary completion 2028-10-11 · NCT05285358 · CT.gov ↗
What to watch
Phase 2MedulloblastomaActive not recruiting
Est. primary completion 2028-10-13 · NCT01878617 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-10-13 · NCT07223047 · CT.gov ↗
What to watch
Phase 3Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine, Doxorubicin, Cisplatin, GemcitabineRecruiting
Est. primary completion 2028-10-31 · NCT06960577 · CT.gov ↗
What to watch
November 2028 (4)
Phase 2Advanced Biliary Tract CarcinomaRecruiting
Est. primary completion 2028-11 · NCT07036380 · CT.gov ↗
What to watch
Phase 2/3Extrahepatic Cholangiocarcinoma, Perihilar Cholangiocarcinoma, Distal Cholangiocarcinoma, Resectable, Borderline ResectableRecruiting
Est. primary completion 2028-11-06 · NCT06923475 · CT.gov ↗
What to watch
Phase 2Advanced Intrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2028-11-19 · NCT06858735 · CT.gov ↗
What to watch
Phase 2Neoplasms of Connective and Soft Tissue With an Unspecified Anatomical SiteNot yet recruiting
Est. primary completion 2028-11-30 · NCT07547592 · CT.gov ↗
What to watch
December 2028 (18)
Phase 2/3Biliary Tract Cancer, CholangiocarcinomaRecruiting
Est. primary completion 2028-12 · NCT06037980 · CT.gov ↗
What to watch
Phase 2Bladder Cancer, Muscle-Invasive Bladder CarcinomaRecruiting
Est. primary completion 2028-12 · NCT06571708 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-12 · NCT07020221 · CT.gov ↗
What to watch
Phase 3Pancreatic CancerRecruiting
Est. primary completion 2028-12 · NCT07079228 · CT.gov ↗
What to watch
Phase 1/2Metastatic Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2028-12 · NCT07475234 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Cancer MetastaticRecruiting
Est. primary completion 2028-12-01 · NCT06030622 · CT.gov ↗
What to watch
Phase 3Biliary Tract CancerRecruiting
Est. primary completion 2028-12-01 · NCT06282575 · CT.gov ↗
What to watch
Phase 2Bladder CancerRecruiting
Est. primary completion 2028-12-01 · NCT06493370 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal Cancinoma (NPC), Nasopharyngeal CancerRecruiting
Est. primary completion 2028-12-01 · NCT06749899 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8Recruiting
Est. primary completion 2028-12-01 · NCT07226856 · CT.gov ↗
What to watch
Phase 2Biliary Tract CancerRecruiting
Est. primary completion 2028-12-30 · NCT07569679 · CT.gov ↗
What to watch
Phase 3Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC) …Recruiting
Est. primary completion 2028-12-30 · NCT07621718 · CT.gov ↗
What to watch
Phase 1/2Urothelial Carcinoma, Bladder CancerActive not recruiting
Est. primary completion 2028-12-31 · NCT03317158 · CT.gov ↗
What to watch
Phase 3NK/T Cell Lymphoma NosRecruiting
Est. primary completion 2028-12-31 · NCT04365036 · CT.gov ↗
What to watch
Phase 1Solid TumorRecruiting
Est. primary completion 2028-12-31 · NCT05382559 · CT.gov ↗
What to watch
Phase 1Bladder Urothelial Carcinoma, Lymph Node MetastasisEnrolling by invitation
Est. primary completion 2028-12-31 · NCT07353294 · CT.gov ↗
What to watch
Phase 2/3Locally Advanced Biliary Tract Adenocarcinoma, Locally Advanced Extrahepatic Cholangiocarcinoma …Not yet recruiting
Est. primary completion 2028-12-31 · NCT07765433 · CT.gov ↗
What to watch
Phase 2Large B-Cell Lymphoma (LBCL), High-grade B-cell LymphomaNot yet recruiting
Est. primary completion 2028-12-31 · NCT07774234 · CT.gov ↗
What to watch
2029 (39)
January 2029 (3)
Phase 3Pancreatic Adenocarcinoma Advanced or MetastaticRecruiting
Est. primary completion 2029-01-01 · NCT06897644 · CT.gov ↗
What to watch
Phase 3Biliary Tract CancerActive not recruiting
Est. primary completion 2029-01-02 · NCT06109779 · CT.gov ↗
What to watch
Phase 2/3Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Carcinoma …Active not recruiting
Est. primary completion 2029-01-15 · NCT06115499 · CT.gov ↗
What to watch
February 2029 (3)
Phase 1Leiomyosarcoma, Soft-tissue SarcomasActive not recruiting
Est. primary completion 2029-02-01 · NCT06308419 · CT.gov ↗
What to watch
Phase 1Biliary Tract MalignanciesRecruiting
Est. primary completion 2029-02-23 · NCT06181032 · CT.gov ↗
What to watch
Phase 2Untreated, Advanced Pancreatic CancerNot yet recruiting
Est. primary completion 2029-02-28 · NCT07578337 · CT.gov ↗
What to watch
March 2029 (2)
April 2029 (5)
Phase 1Diffuse Pleural Mesothelioma, Gastroesophageal Carcinoma, Urothelial CarcinomaRecruiting
Est. primary completion 2029-04 · NCT07532902 · CT.gov ↗
What to watch
Phase 2Borderline Resectable Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2029-04 · NCT07616362 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-04 · NCT07699757 · CT.gov ↗
What to watch
Phase 2Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8Recruiting
Est. primary completion 2029-04-30 · NCT06029270 · CT.gov ↗
What to watch
Phase 3Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8Active not recruiting
Est. primary completion 2029-04-30 · NCT06632327 · CT.gov ↗
What to watch
May 2029 (2)
Phase 1/2Pancreas Ductal Adenocarcinoma, Pancreas Cancer, Metastatic, Pancreatic Adenocarcinoma Metastatic, Adenosquamous Carcinoma of the Pancreas …Not yet recruiting
Est. primary completion 2029-05 · NCT07665684 · CT.gov ↗
What to watch
Phase 2/3Pancreatic Ductal AdenocarcinomaActive not recruiting
Est. primary completion 2029-05-03 · NCT07076121 · CT.gov ↗
What to watch
June 2029 (2)
July 2029 (4)
Phase 2PDAC - Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2029-07 · NCT07028424 · CT.gov ↗
What to watch
Phase 2/3Gall Bladder CancerRecruiting
Est. primary completion 2029-07-21 · NCT06214572 · CT.gov ↗
What to watch
Phase 2Hodgkin Lymphoma, Adult, Refractory Hodgkin Lymphoma, Classic Hodgkin LymphomaRecruiting
Est. primary completion 2029-07-31 · NCT07021989 · CT.gov ↗
What to watch
Phase 3Biliary Tract CancerRecruiting
Est. primary completion 2029-07-31 · NCT07221253 · CT.gov ↗
What to watch
September 2029 (3)
Phase 1HR+/HER2- Metastatic Breast CancerActive not recruiting
Est. primary completion 2029-09 · NCT04796220 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-09 · NCT07563738 · CT.gov ↗
What to watch
Phase 2Stage III Lung Cancer AJCC v8, Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Cancer AJCC v8 …Recruiting
Est. primary completion 2029-09-30 · NCT04892953 · CT.gov ↗
What to watch
October 2029 (3)
Phase 2Phase 2 Study, BMS-986504, MTAP-deleted Pancreatic CancerRecruiting
Est. primary completion 2029-10-01 · NCT07283705 · CT.gov ↗
What to watch
Phase 2Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified …Recruiting
Est. primary completion 2029-10-15 · NCT07365306 · CT.gov ↗
What to watch
Phase 2Classic Hodgkin LymphomaRecruiting
Est. primary completion 2029-10-20 · NCT07275216 · CT.gov ↗
What to watch
November 2029 (2)
December 2029 (10)
Phase 3Extranodal NK/T-cell LymphomaNot yet recruiting
Est. primary completion 2029-12 · NCT05700448 · CT.gov ↗
What to watch
Phase 3HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2029-12 · NCT07173751 · CT.gov ↗
What to watch
Phase 3Advanced Biliary Tract CancerRecruiting
Est. primary completion 2029-12 · NCT07229625 · CT.gov ↗
What to watch
Phase 3Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) …Not yet recruiting
Est. primary completion 2029-12 · NCT07464145 · CT.gov ↗
What to watch
Phase 2Bile Duct CancerRecruiting
Est. primary completion 2029-12-30 · NCT06274879 · CT.gov ↗
What to watch
Phase 2Non-Muscle-Invasive Bladder Cancer, BCG-Unresponsive Bladder CancerRecruiting
Est. primary completion 2029-12-30 · NCT07747740 · CT.gov ↗
What to watch
Phase 2Non Muscle Invasive Bladder CancerRecruiting
Est. primary completion 2029-12-31 · NCT06972615 · CT.gov ↗
What to watch
Phase 3Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 …Recruiting
Est. primary completion 2029-12-31 · NCT06998940 · CT.gov ↗
What to watch
Phase 1/2Intrahepatic Cholangiocarcinoma (Icc)Not yet recruiting
Est. primary completion 2029-12-31 · NCT07632235 · CT.gov ↗
What to watch
Phase 1/2Metastatic Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2029-12-31 · NCT07640295 · CT.gov ↗
What to watch
2030 (22)
January 2030 (2)
February 2030 (1)
Phase 2Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2030-02-03 · NCT07748611 · CT.gov ↗
What to watch
April 2030 (3)
Phase 2Metastatic Urothelial CancerActive not recruiting
Est. primary completion 2030-04 · NCT03547973 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2030-04 · NCT05257993 · CT.gov ↗
What to watch
Phase 3Biliary Tract CancerRecruiting
Est. primary completion 2030-04-30 · NCT07710885 · CT.gov ↗
What to watch
May 2030 (1)
Phase 3Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8Recruiting
Est. primary completion 2030-05-31 · NCT07097142 · CT.gov ↗
What to watch
June 2030 (3)
Phase 2/3Locally Advanced Triple-negative Breast Cancer, Metastatic Triple-negative Breast CancerRecruiting
Est. primary completion 2030-06 · NCT07544056 · CT.gov ↗
What to watch
Phase 1Metastatic Biliary Tract Cancer, Metastatic Biliary Tract CarcinomaRecruiting
Est. primary completion 2030-06-30 · NCT07107750 · CT.gov ↗
What to watch
Phase 3Pancreatic CancerNot yet recruiting
Est. primary completion 2030-06-30 · NCT07383922 · CT.gov ↗
What to watch
July 2030 (1)
Phase 2Diffuse Large B Cell Lymphoma (DLBCL)Not yet recruiting
Est. primary completion 2030-07-21 · NCT07599423 · CT.gov ↗
What to watch
August 2030 (2)
Phase 3Metastatic Bladder Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Refractory Bladder Urothelial Carcinoma …Active not recruiting
Est. primary completion 2030-08-15 · NCT04579224 · CT.gov ↗
What to watch
Phase 3Pancreatic Cancer ResectableNot yet recruiting
Est. primary completion 2030-08-31 · NCT07155629 · CT.gov ↗
What to watch
September 2030 (2)
October 2030 (1)
Phase 2Aggressive B-Cell LymphomaNot yet recruiting
Est. primary completion 2030-10-01 · NCT07184788 · CT.gov ↗
What to watch
November 2030 (2)
Phase 2Bladder Cancer, Non-muscle Invasive Bladder Cancer, Low GradeNot yet recruiting
Est. primary completion 2030-11-30 · NCT06227065 · CT.gov ↗
What to watch
Phase 3Metastatic Pancreatic Ductal AdenocarcinomaActive not recruiting
Est. primary completion 2030-11-30 · NCT06608927 · CT.gov ↗
What to watch
December 2030 (4)
Phase 1/2Pancreatic Ductal Adenocarcinoma (PDAC), Borderline Resectable Pancreatic Cancer, Pancreatic NeoplasmsNot yet recruiting
Est. primary completion 2030-12 · NCT07477418 · CT.gov ↗
What to watch
Phase 2Resectable Intrahepatic CholangiocarcinomaNot yet recruiting
Est. primary completion 2030-12-10 · NCT07639528 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic CancerActive not recruiting
Est. primary completion 2030-12-31 · NCT04589234 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-12-31 · NCT07050043 · CT.gov ↗
What to watch
2031 (3)
February 2031 (1)
Phase 2Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements …Recruiting
Est. primary completion 2031-02-22 · NCT03418038 · CT.gov ↗
What to watch
March 2031 (1)
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2031-03-01 · NCT05919537 · CT.gov ↗
What to watch
June 2031 (1)
Phase 2/3Pancreatic Cancer, Advanced or Metastatic, BRCA1/2 Mutation, PALB2 Gene MutationActive not recruiting
Est. primary completion 2031-06-02 · NCT06783140 · CT.gov ↗
What to watch
2032 (4)
February 2032 (1)
Phase 2Lung Neoplasm MalignantActive not recruiting
Est. primary completion 2032-02-06 · NCT06788912 · CT.gov ↗
What to watch
April 2032 (1)
Phase 1/2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2032-04-30 · NCT05981001 · CT.gov ↗
What to watch
December 2032 (2)
Phase 3Locally Advanced Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Carcinoma, Pancreas Cancer, Neoadjuvant Chemotherapy, Surgery …Recruiting
Est. primary completion 2032-12-31 · NCT06714604 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal CarcinomaNot yet recruiting
Est. primary completion 2032-12-31 · NCT07540390 · CT.gov ↗
What to watch
2033 (6)
January 2033 (1)
Phase 2Bladder Cancer, Non-Muscle Invasive Bladder Cancer (NMIBC), Urothelial Carcinoma, Carcinoma in Situ (CIS) …Recruiting
Est. primary completion 2033-01-01 · NCT07322263 · CT.gov ↗
What to watch
April 2033 (1)
Phase 3Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2033-04-01 · NCT05314998 · CT.gov ↗
What to watch
May 2033 (1)
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2033-05-16 · NCT06623422 · CT.gov ↗
What to watch
June 2033 (1)
Phase 2Natural Killer/T-cell LymphomaNot yet recruiting
Est. primary completion 2033-06-30 · NCT07768943 · CT.gov ↗
What to watch
July 2033 (1)
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2033-07 · NCT04198766 · CT.gov ↗
What to watch
December 2033 (1)
Phase 3Nasopharyngeal Carcinoma (NPC)Not yet recruiting
Est. primary completion 2033-12 · NCT07783321 · CT.gov ↗
What to watch
2034 (1)
June 2034 (1)
Phase 2Triple Negative Breast Cancer, Metastatic Triple-negative Breast CancerNot yet recruiting
Est. primary completion 2034-06-01 · NCT07528768 · CT.gov ↗
What to watch
2035 (1)
December 2035 (1)
Phase 2Recurrent Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNSRecruiting
Est. primary completion 2035-12-31 · NCT07447076 · CT.gov ↗
What to watch
2038 (1)
December 2038 (1)
Phase 2Metastatic Colorectal CancerRecruiting
Est. primary completion 2038-12-31 · NCT05725200 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.